Literature DB >> 16221051

Treatment options for brain metastases from melanoma.

Robert R McWilliams1, Ravi D Rao, Paul D Brown, Michael J Link, Jan C Buckner.   

Abstract

Brain metastases are a common complication of metastatic malignant melanoma, conferring an exceedingly poor prognosis. Diagnosis of brain metastasis often has significant implications for duration and quality of life, and management can be difficult due to rapid progression of disease and resistance to conventional therapies. This review focuses primarily on the published evidence for treatment modalities for brain metastases from melanoma, emerging technologies and outlines future directions for research. In summary, external-beam radiation alone appears effective in palliating symptoms. Surgical management of solitary or acutely symptomatic lesions appears to alleviate symptoms and provide the possibility of local control of disease. Stereotactic radiosurgery is an increasingly utilized technique for patients with a limited number of metastases and presents a less-invasive alternative to craniotomy. Chemotherapy alone is relatively ineffective, although combined chemotherapy with external-beam radiation is being investigated. Future directions include combined modality therapy, the incorporation of novel agents and careful consideration of the structure of clinical trials for this disease.

Entities:  

Mesh:

Year:  2005        PMID: 16221051     DOI: 10.1586/14737140.5.5.809

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  5 in total

Review 1.  The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs.

Authors:  Robert R Langley; Isaiah J Fidler
Journal:  Int J Cancer       Date:  2011-03-25       Impact factor: 7.396

2.  Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels.

Authors:  Qingtang Lin; Krishnakumar Balasubramanian; Dominic Fan; Sun-Jin Kim; Lixia Guo; Hua Wang; Menashe Bar-Eli; Kenneth D Aldape; Isaiah J Fidler
Journal:  Neoplasia       Date:  2010-09       Impact factor: 5.715

3.  Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.

Authors:  Delphine Lamoral-Theys; Anna Andolfi; Gwendoline Van Goietsenoven; Alessio Cimmino; Benjamin Le Calvé; Nathalie Wauthoz; Véronique Mégalizzi; Thierry Gras; Céline Bruyère; Jacques Dubois; Véronique Mathieu; Alexander Kornienko; Robert Kiss; Antonio Evidente
Journal:  J Med Chem       Date:  2009-10-22       Impact factor: 7.446

4.  Targeted cellular ionic calcium chelation by oxalates: Implications for the treatment of tumor cells.

Authors:  Abraham Embi; Benjamin J Scherlag; Peter J Embi; Manuel Menes; Sunny S Po
Journal:  Cancer Cell Int       Date:  2012-12-08       Impact factor: 5.722

Review 5.  Emerging findings into molecular mechanism of brain metastasis.

Authors:  Wenting Ni; Wenxing Chen; Yin Lu
Journal:  Cancer Med       Date:  2018-07-10       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.